Bath salts toxicity: Difference between revisions
m (moved Synthetic Cannabinoids (Bath Salts) to Bath Salts: Bath salts aren't synthetic cannabinoids) |
No edit summary |
||
| Line 1: | Line 1: | ||
== Background == | == Background == | ||
*Found in herbal products sold | *Found in herbal products sold under guise of "not for human consumption" | ||
**May be found under brand name Aura, Ivory wave, Vanilla sky | **May be found under brand name Aura, Ivory wave, Vanilla sky | ||
*Active ingredients vary | *Active ingredients vary; often contain methylenedioxyprovalerone (MDPV) or mephedrone | ||
*Similar effects to MDMA, cocaine, methamphetamines | *Similar effects to MDMA, cocaine, methamphetamines | ||
| Line 31: | Line 29: | ||
== Treatment == | == Treatment == | ||
*Benzodiazepines or | *Benzodiazepines or haldol for agitation | ||
*Rapid cooling for hyperthermia | *Rapid cooling for hyperthermia | ||
*IV hydration | *IV hydration | ||
*Monitor urine output | *Monitor urine output | ||
== Disposition == | == Disposition == | ||
* | *Discharge if AMS and sympathomimetic symptoms resolve w/o e/o end-organ damage | ||
*Admit | *Admit for lab abnormalities or persistent AMS | ||
== Sources == | == Sources == | ||
* | *UpToDate | ||
*EMRAP | *EMRAP | ||
[[Category: Tox]] | [[Category: Tox]] | ||
Revision as of 03:53, 5 January 2012
Background
- Found in herbal products sold under guise of "not for human consumption"
- May be found under brand name Aura, Ivory wave, Vanilla sky
- Active ingredients vary; often contain methylenedioxyprovalerone (MDPV) or mephedrone
- Similar effects to MDMA, cocaine, methamphetamines
Clinical features
- Sympathomimetic toxidrome
- Tachycardia
- Hypertension
- Agitation
- Paranoia
- Hyperthermia
- Hallucinogenic
Diagnosis
- Diagnosis based on history and physical exam
Work-Up
- Fingerstick glucose
- Complete metabolic panel
- LFTs
- Coags
- Total CK
- Utox not helpful, usually negative
DDX
Treatment
- Benzodiazepines or haldol for agitation
- Rapid cooling for hyperthermia
- IV hydration
- Monitor urine output
Disposition
- Discharge if AMS and sympathomimetic symptoms resolve w/o e/o end-organ damage
- Admit for lab abnormalities or persistent AMS
Sources
- UpToDate
- EMRAP